Tag: Sciences

New Amsterdam Sciences Announces Pre-IND Stage 2 Submission with FDA Coronavirus Treatment Velocity Program for NAS150

  Brand-new Amsterdam Sciences, an independently held business, reveals the filing of the Business’s recently offered products and information with the FDA’s coronavirus treatment velocity program as a pre-Investigation New Drug Stage 2 submission. The FDA submission is for the development of the Business’s restorative representative prospect NAS150 for the treatment of COVID-19 which is triggered by the SARS-CoV-2 infection and its versions. The Business is likewise positive that NAS150 would be therapeutically advantageous for dealing with other viral illness such as pneumonia, seasonal and pandemic influenza. In Addition, New Amsterdam Sciences Stage 2 Pre-IND is currently authorized for expedition ... Read more

Caris Life Sciences Launches HLA Genotype Reporting, the Newest Addition to its Suite of Comprehensive Molecular Science Offerings

Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced the launch of Human Leukocyte Antigen (HLA) Genotype reporting, the newest addition to the Company’s suite of comprehensive molecular science offerings. As an emerging biomarker in the treatment of cancer, HLA genes play an integral role in activating T-cells to induce an immune response and may contribute to a patient’s response to cancer immunotherapies. Caris HLA Genotype reporting builds upon the most expansive molecular intelligence available and strengthens physicians’ ability to provide more individualized treatment decisions for their patients. ... Read more